» Articles » PMID: 37046817

The Role of Exosomes in Epithelial-to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Apr 13
PMID 37046817
Authors
Affiliations
Soon will be listed here.
Abstract

Exosomes are nanosized vesicles that are produced in normal and cancer cells, promoting intracellular communication. In head and neck cancer (HNC), exosomes are involved in many undesirable events of cancer development and progression, including angiogenesis, tumor microenvironment (TME) remodeling, invasion, epithelial-to-mesenchymal transition (EMT), metastasis, extracellular matrix (ECM) degradation, and drug resistance. Exosomes are involved in altering the signaling pathways in recipient cells by the cargoes they carry. Proteins, lipids, and nucleic acids such as DNA fragments and RNAs (i.e., mRNAs, miRNAs, and long non-coding RNAs) are carried in the exosomes to promote cell communication. EMT is a critical cellular process in which epithelial cells are forced to become mesenchymal cells by the actions of SNAIL/SLUG, TWIST, and ZEB family transcription factors carried in exosomes that facilitate metastasis. In this critical review, we focused on exosome biogenesis, their cargoes, and their involvement in EMT induction and metastasis during HNC. Insights into exosome isolation and characterization, as well as their key role in ECM remodeling and degradation, are also presented and critically discussed. More importantly, this article addresses the role of exosomes in HNC and drug resistance induced in drug-sensitive cancer cells. In addition, exosomes have a great potential to be used as diagnostic and therapeutic tools. A better understanding on exosome biogenesis, composition, and functions in HNC will aid in developing novel therapeutic strategies to treat HNC, overcome therapy resistance, and avoid metastasis, which is a significant cause of cancer death.

Citing Articles

Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition.

Glaviano A, Lau H, Carter L, Lee E, Lam H, Okina E J Hematol Oncol. 2025; 18(1):6.

PMID: 39806516 PMC: 11733683. DOI: 10.1186/s13045-024-01634-6.


Growth Hormone Upregulates Melanoma Drug Resistance and Migration via Melanoma-Derived Exosomes.

Kulkarni P, Basu R, Bonn T, Low B, Mazurek N, Kopchick J Cancers (Basel). 2024; 16(15).

PMID: 39123364 PMC: 11311539. DOI: 10.3390/cancers16152636.


Role of Exosomes in Cancer and Aptamer-Modified Exosomes as a Promising Platform for Cancer Targeted Therapy.

Wu Y, Cao Y, Chen L, Lai X, Zhang S, Wang S Biol Proced Online. 2024; 26(1):15.

PMID: 38802766 PMC: 11129508. DOI: 10.1186/s12575-024-00245-2.

References
1.
Luo D, Zhan S, Xia W, Huang L, Ge W, Wang T . Proteomics study of serum exosomes from papillary thyroid cancer patients. Endocr Relat Cancer. 2018; 25(10):879-891. DOI: 10.1530/ERC-17-0547. View

2.
Montecalvo A, Larregina A, Shufesky W, Stolz D, Sullivan M, Karlsson J . Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood. 2011; 119(3):756-66. PMC: 3265200. DOI: 10.1182/blood-2011-02-338004. View

3.
Tao S, Guo S . Extracellular Vesicles: Potential Participants in Circadian Rhythm Synchronization. Int J Biol Sci. 2018; 14(12):1610-1620. PMC: 6216034. DOI: 10.7150/ijbs.26518. View

4.
Zhong H, Li X, Zhang J, Wu X . Overexpression of periostin is positively associated with gastric cancer metastasis through promoting tumor metastasis and invasion. J Cell Biochem. 2019; 120(6):9927-9935. DOI: 10.1002/jcb.28275. View

5.
Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M . Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007; 67(5):1970-8. DOI: 10.1158/0008-5472.CAN-06-3933. View